Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 20/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 9/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 9/20 | 0.46 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | DRD1 | P21728 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21573505 | 0.95 | ADRB2 (0.50) | ADRB2CHRM3ADRB1DRD2DRD1 | |
| SCHEMBL21573503 | 0.93 | ADRB2 (0.50) | ADRB2CHRM3ADRB1 | |
| SCHEMBL21568678 | 0.88 | ADRB2 (0.56) | ADRB2CHRM3ADRB1 | |
| SCHEMBL21568679 | 0.88 | ADRB2 (0.56) | ADRB2CHRM3ADRB1 | |
| SCHEMBL18260021 | 0.86 | ADRB2 (0.69) | ADRB2CHRM3 | |
| SCHEMBL18260024 | 0.86 | ADRB2 (0.69) | ADRB2CHRM3 | |
| SCHEMBL28341161 | 0.86 | ADRB2 (0.69) | ADRB2CHRM3 | |
| SCHEMBL21573549 | 0.85 | ADRB2 (0.56) | ADRB2CHRM3ADRB1 | |
| SCHEMBL21568555 | 0.83 | ADRB2 (0.53) | ADRB2CHRM3ADRB1DRD2DRD1 | |
| SCHEMBL21568557 | 0.83 | ADRB2 (0.53) | ADRB2CHRM3ADRB1DRD2DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9662323-B2 | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | CHIESI FARMACEUTICI S.P.A. (IT) | 2017-05-30 | — | — | US | disclosed |